Who makes DCVAC add on to SOC?

DCVAC add on to SOC is developed by SOTIO a.s..

What development phase is DCVAC add on to SOC in?

DCVAC add on to SOC is in Phase 1.

Last reviewed 2026-04-19 · How we verify

DCVAC add on to SOC

SOTIO a.s. · Phase 1 active Biologic

At a glance

Generic name	DCVAC add on to SOC
Sponsor	SOTIO a.s.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer (PHASE1, PHASE2)
Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DCVAC add on to SOC CI brief — competitive landscape report
DCVAC add on to SOC updates RSS · CI watch RSS
SOTIO a.s. portfolio CI